Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Cencora, Inc. Common Stock (NY:COR)

299.42 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Jun 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cencora, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >
2 Surging Stocks to Research Further and 1 to Be Wary Of
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
Via Benzinga
3 S&P 500 Stocks to Own for Decades
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
$100 Invested In Cencora 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Top S&P500 movers in Thursday's session
Join us in exploring the top gainers and losers within the S&P500 index one hour before the close of the markets on Thursday as we examine the latest happenings in today's session. 
Via Chartmill
$100 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
COR Q1 Earnings Call: Specialty Expansion, RCA Impact, and International Softness Highlight Results
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above... 
Via StockStory
1 Safe-and-Steady Stock to Target This Week and 2 to Think Twice About
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
3 Market-Beating Stocks with Promising Prospects
The best-performing stocks typically have robust sales growth, increasing margins, and rising returns on capital, and those that can maintain this trifecta year in and year out often become the legends... 
Via StockStory
Assessing Cencora: Insights From 6 Financial Analysts
Via Benzinga
What's Driving the Market Sentiment Around Cencora?
Via Benzinga
Earnings Scheduled For May 7, 2025
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Cencora Elects Lori J. Ryerkerk to Its Board of Directors
From Cencora
Via Business Wire
If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Top S&P500 movers in Monday's pre-market session
Stay updated with the S&P500 stocks that are on the move in today's pre-market session. 
Via Chartmill
Top S&P500 movers in Thursday's session
Let's delve into the developments on the US markets one hour before the close of the markets on Thursday. Below, you'll find the top gainers and losers within the S&P500 index during today's session. 
Via Chartmill
Discover which S&P500 stocks are making waves on Thursday.
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview. 
Via Chartmill
Thursday's session: gap up and gap down stock in the S&P500 index
Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Top S&P500 movers in Wednesday's session
Curious about the top performers within the S&P500 index one hour before the close of the markets on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive... 
Via Chartmill
Cencora's Boosts Annual Forecast On Strong Demand For Weight Loss Drugs, Specialty Products Despite Mixed Q2 Earnings
Cencora raised its 2025 earnings forecast after a strong Q2 driven by U.S. drug sales, though total revenue of $75.5 billion slightly missed expectations. 
Via Benzinga
Cencora Reports Upbeat Q2 Earnings, Revises Fiscal Year 2025 Guidance: Retail’s Pleased
The company raised its fiscal year 2025 adjusted EPS guidance to $15.70 to $15.95 compared to a previous range of $15.30 to $15.60. 
Via Stocktwits
Cencora’s (NYSE:COR) Q1 Earnings Results: Revenue In Line With Expectations
Healthcare distributor Cencora (NYSE:COR) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 10.3% year on year to $75.45 billion. Its non-GAAP profit of $4.42 per share was 7.9% above... 
Via StockStory
Topics Economy
Cencora Reports Fiscal 2025 Second Quarter Results
From Cencora
Via Business Wire
Cencora Earnings: What To Look For From COR
Healthcare distributor Cencora (NYSE:COR) will be reporting earnings tomorrow before the bell. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
Indications Suggest CENCORA INC (NYSE:COR) Could Be on the Verge of a Breakout.
CENCORA INC (NYSE:COR) has a good technical rating of 10 out of 10 and could possibly break out. 
Via Chartmill
Here's How Much You Would Have Made Owning Cencora Stock In The Last 5 Years
Via Benzinga
3 S&P 500 Stocks with Impressive Fundamentals
The biggest companies in the world call the S&P 500 (^GSPC) home, but only a handful are still growing rapidly. Some of these industry leaders are executing exceptionally well and rewarding... 
Via StockStory
Topics Stocks
Here's How Much You Would Have Made Owning Cencora Stock In The Last 10 Years
Via Benzinga
Top S&P500 movers in Thursday's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top S&P500 gainers and losers in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.